Association between pulmonary function and sputum biomarkers in cystic fibrosis.
about
Antioxidant supplementation for lung disease in cystic fibrosisAntioxidant micronutrients for lung disease in cystic fibrosisNeutrophil elastase and matrix metalloproteinase 12 in cystic fibrosis lung diseaseAdvancing clinical development pathways for new CFTR modulators in cystic fibrosisCleavage of CXCR1 on neutrophils disables bacterial killing in cystic fibrosis lung diseaseLung transplantation for cystic fibrosisPolymorphonuclear leukocytes restrict growth of Pseudomonas aeruginosa in the lungs of cystic fibrosis patients.Smartphone-Based pH Sensor for Home Monitoring of Pulmonary Exacerbations in Cystic Fibrosis.Release of cystic fibrosis airway inflammatory markers from Pseudomonas aeruginosa-stimulated human neutrophils involves NADPH oxidase-dependent extracellular DNA trap formation.Update in cystic fibrosis 2012.2-O, 3-O-desulfated heparin inhibits neutrophil elastase-induced HMGB-1 secretion and airway inflammation.Anti-PcrV antibody in cystic fibrosis: a novel approach targeting Pseudomonas aeruginosa airway infection.Year-to-year changes in lung function in individuals with cystic fibrosis.Acute inhalation of hypertonic saline does not improve mucociliary clearance in all children with cystic fibrosis.Isolation and characterization of microparticles in sputum from cystic fibrosis patientsSputum biomarkers and the prediction of clinical outcomes in patients with cystic fibrosis.Lack of neutrophil elastase reduces inflammation, mucus hypersecretion, and emphysema, but not mucus obstruction, in mice with cystic fibrosis-like lung disease.Identification of neutrophil activation markers as novel surrogate markers of CF lung disease.IP-10 is a potential biomarker of cystic fibrosis acute pulmonary exacerbationsThe blood neutrophil to lymphocyte ratio correlates with clinical status in children with cystic fibrosis: a retrospective studyFRET-based and other fluorescent proteinase probes.Using bacterial biomarkers to identify early indicators of cystic fibrosis pulmonary exacerbation onsetPharmacokinetics and tolerability of oral sildenafil in adults with cystic fibrosis lung diseaseThe ferrous iron-responsive BqsRS two-component system activates genes that promote cationic stress tolerance.Potential of anti-inflammatory treatment for cystic fibrosis lung disease.Correlations of salivary biomarkers with clinical assessments in patients with cystic fibrosis.SerpinB1 in cystic fibrosis airway fluids: quantity, molecular form and mechanism of elastase inhibition.Metabolomic Evaluation of Neutrophilic Airway Inflammation in Cystic Fibrosis.Omics approaches in cystic fibrosis research: a focus on oxylipin profiling in airway secretions.Cystic fibrosis-adapted Pseudomonas aeruginosa quorum sensing lasR mutants cause hyperinflammatory responses.Transcription of Interleukin-8: How Altered Regulation Can Affect Cystic Fibrosis Lung Disease.Sputum biomarkers of inflammation and lung function decline in children with cystic fibrosisExhaled breath condensate adenosine tracks lung function changes in cystic fibrosis.Advancing outcome measures for the new era of drug development in cystic fibrosis.Sputum biomarkers of inflammation in cystic fibrosis lung diseaseProteases and cystic fibrosis.Update in cystic fibrosis 2007.Interleukin-17 Pathophysiology and Therapeutic Intervention in Cystic Fibrosis Lung Infection and Inflammation.Progress in cystic fibrosis and the CF Therapeutics Development NetworkHighlights of a workshop to discuss targeting inflammation in cystic fibrosis
P2860
Q24194437-539A66C9-D78E-4460-BB41-B5E17BCC1A33Q24235655-B9C76BE9-5EE4-4035-84DE-5DAB70842D54Q26741691-DC07F1C1-2C40-4437-B838-FCCD8542252BQ26768266-3B2773B0-DDC2-4B2E-9B98-E39A5F2F7C2DQ28259959-C5F11FB5-AA98-4FA4-8E53-1DF205A45237Q28749501-8F1FF07D-03E9-4E41-BD1C-BD375DD6E184Q30842136-5AE7DD12-BDA2-4ACB-A35B-9BF57EEB80C6Q33454731-D068CC7F-6125-4946-AB0D-755AADEB8186Q33654992-22956349-EEF7-48C3-98E1-8B1C92B7EF88Q33738510-70482BF1-32B2-4888-B0C2-D1102FD99625Q33799602-153FF7E1-DF10-4BB3-8BB4-650C22589AB7Q33836925-A0673229-FAA4-42DF-A6C1-35E094FAB45DQ33918035-D56611C9-3FFF-44D5-A0F2-5066F1814FDDQ34012366-E569D5C5-2952-433E-87D3-F3D85BD0BBE3Q34020055-411B4057-CA0E-44E5-89C7-84889596A5EEQ34390999-75287DF9-6F05-4523-9BAB-0E80911F2A87Q34412599-4A6E096B-7F91-4C68-AF8A-DF40B650D113Q34784319-32D38AC7-D27A-4332-B9A6-3F34BB4F74EDQ34973839-F3644B8F-B8D8-4B20-B61E-59FDF7393963Q35009766-333AB11C-5D16-44A9-AD35-466EC079909DQ35086168-22481433-3E72-409D-8F44-E38FAF63324AQ35143420-215E4A28-6492-462C-993B-5646F7FA7EEFQ35164509-6D9907AC-C829-498B-B1E4-0F176F92C4AFQ35172351-A7CA5341-F5E1-4129-8B5D-9DFD5EDD679CQ35557381-25BEB0DE-92A0-42CA-A061-DE5408F49C0CQ35741301-10612AA9-B7FF-4555-A78F-8B30A02FA0B2Q35776816-876ACBCB-AAF8-4B27-BF22-8C61DD60CB5FQ35914614-ABC3842F-90E8-41E3-9F5C-2C8792521DEAQ36112019-F62CCCB9-4E20-4B90-ABD9-D84E011E2C65Q36135733-2E456BE8-D0B2-4259-B297-69E73BD69103Q36139057-7045C55E-FCF1-4B6D-8966-AF9284E4BC9DQ36488777-F58A0254-4A33-4E48-B56B-BEC09432D9E9Q36770672-A05D32C1-C79E-4706-AC86-60E01141B10CQ36891530-CA923653-2DEB-4107-BBBD-BCFBECE8D196Q36891552-01155CE6-B723-46E3-B9B3-BC7CB9F21841Q37131650-56E023E2-4CB9-46CB-AA75-4E6F732662E7Q37156059-F1829D08-EF02-47E9-AD56-DAB2AAB9E100Q37199853-14263773-9384-42A7-BFDA-AE41E3D9A84BQ37209004-F14B75DD-F138-421C-87B5-78E5A9CF0BE6Q37330935-146FB908-1FDA-4D8F-9525-ACBC8FCA4D5D
P2860
Association between pulmonary function and sputum biomarkers in cystic fibrosis.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 18 January 2007
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Association between pulmonary function and sputum biomarkers in cystic fibrosis.
@en
Association between pulmonary function and sputum biomarkers in cystic fibrosis.
@nl
type
label
Association between pulmonary function and sputum biomarkers in cystic fibrosis.
@en
Association between pulmonary function and sputum biomarkers in cystic fibrosis.
@nl
prefLabel
Association between pulmonary function and sputum biomarkers in cystic fibrosis.
@en
Association between pulmonary function and sputum biomarkers in cystic fibrosis.
@nl
P2093
P2860
P921
P1476
Association between pulmonary function and sputum biomarkers in cystic fibrosis.
@en
P2093
Bonnie W Ramsey
Frank J Accurso
Jane L Burns
Michael W Konstan
Moira L Aitken
Nicole Mayer-Hamblett
Richard A Kronmal
Scott D Sagel
P2860
P304
P356
10.1164/RCCM.200609-1354OC
P407
P577
2007-01-18T00:00:00Z